Abstracts tagged "Clinical research and psoriatic arthritis"

Abstract Number: 2554 • 2018 ACR/ARHP Annual Meeting
Abatacept without Methotrexate in Patients with Active Psoriatic Arthritis: A Post Hoc Analysis of a Phase III, Randomized Study
Vibeke Strand¹, Thomas Lehman², Harris A Ahmad², Alyssa Johnsen², Sandhya Balachandar² and Philip J. Mease³, ¹Stanford University, Palo Alto, CA, ²Bristol-Myers Squibb, Princeton, NJ, ³Swedish Medical Center and University of Washington School of Medicine, Seattle, WA
Background/Purpose: In the randomized, placebo (pbo)-controlled Phase III ASTRAEA study (ClinicalTrials.gov, NCT01860976) patients (pts) with active psoriatic arthritis (PsA) were randomized to abatacept (ABA) or…
Abstract Number: 1041 • 2016 ACR/ARHP Annual Meeting
Abatacept in the Treatment of Active Psoriatic Arthritis: 24-Week Results from a Phase III Study
P Mease¹, AB Gottlieb², D van der Heijde³, Oliver FitzGerald⁴, A Johnsen⁵, M Nys⁶, S Banerjee⁵ and D Gladman⁷, ¹Swedish Medical Center and University of Washington, Seattle, WA, ²Tufts University School of Medicine (affiliation at the time of the study), Boston, MA, ³Leiden University Medical Center, Leiden, Netherlands, ⁴Department of Rheumatology, St Vincent’s University Hospital and University College Dublin, Dublin, Ireland, ⁵Bristol-Myers Squibb, Princeton, NJ, ⁶Bristol-Myers Squibb, Braine-l’Alleud, Belgium, ⁷Rheumatology, University of Toronto and Toronto Western Hospital, Toronto, ON, Canada
Background/Purpose: Abatacept (ABA), a selective T-cell co-stimulation modulator, showed promise for the treatment of PsA in a Phase II trial.1 This prompted the conduct of…
Abstract Number: 1852 • 2014 ACR/ARHP Annual Meeting
Increased Cardiovascular Risk in Patients Recently Diagnosed with Psoriatic Arthritis: A Population-Based, Cohort Study
Katelynn Wilton¹, Floranne C. Ernste², Cynthia S. Crowson³, Eric L. Matteson⁴, Hilal Maradit Kremers⁵ and Marta Sánchez-Menéndez⁶, ¹Medical Scientist Training Program, Mayo Clinic Rochester, Rochester, MN, ²Division of Rheumatology, Mayo Clinic Rochester, Rochester, MN, ³Department of Health Sciences Research, Mayo Clinic, Rochester, MN, ⁴Rheumatology, Mayo Clinic, Rochester, MN, ⁵Health Sciences Research, Mayo Clinic, Rochester, MN, ⁶Centro Medico de Asturias, Oviedo, Spain
Background/Purpose: Patients diagnosed with rheumatoid arthritis and psoriatic arthritis (PsA) have an increased risk of multiple comorbidities that predispose them to cardiovascular disease (CVD). Although…
Abstract Number: 327 • 2013 ACR/ARHP Annual Meeting
Major Differences In The Pattern Of Joint Swelling and Tenderness In a Large Psoriatic Arthritis Cohort – Results From An Exploratory Hierarchical Cluster Analysis
Burkhard Möller¹, Daniel Stekhoven² and Peter M. Villiger³, ¹Rheumatology, Inselspital, Bern, Switzerland, ²Swiss Clinical Quality Management in Rheumatic Diseases-SCQM Foundation, Zurich, Switzerland, ³Rheumatology, Immunology and Allergology, University Hospital Bern, Bern, Switzerland
Background/Purpose: Psoriatic arthritis (PsA) shows the largest complexity in joint involvement among all inflammatory types of arthritis. In order to improve feasibility and to reduce…